14
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      NVVC/NHJ Durrer prizes 2018

      editorial
      Netherlands Heart Journal
      Bohn Stafleu van Loghum

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The NVVC/NHJ publication prizes are named after one of the founding fathers of Dutch Cardiology, professor D. Durrer (1918–1984) who was the chair of the department of Cardiology at the former Wilhelmina Gasthuis in Amsterdam. He was an outstanding pioneer in the field of electrophysiology with classical works on the electric activation of the heart in the 1960s and 1970s [1]. In 1972, he also founded the Interuniversity Cardiology Institute of the Netherlands (ICIN). Moreover, the Durrer Center, founded in 2008, carries his name in his memory. The Durrer Center is a national multidisciplinary collaboration of academic research institutes in the field of cardiology, genetics and biostatistics. The Netherlands Heart Journal, the official journal of the Netherlands Society of Cardiology (NVVC), awarded the Durrer prizes to two outstanding NHJ articles published in 2018. These articles are selected based upon their originality and scientific quality as well as the number of citations. The two articles were selected out of a total of 123 articles published in the NHJ 2018. The first article entitled ‘Extracorporeal life support in cardiogenic shock: indications and management in current practice’ is a review of veno-arterial extracorporeal life support (VA-ECLS). This device is increasingly being used as a cardiac and circulatory support modality with the ability to provide immediate stabilisation in patients with otherwise refractory cardiogenic shock [2]. This review was carried out to assess the current available evidence in the absence of randomised trials. Observational studies on VA-ECLS have suggested a reduction in mortality as compared to conventional treatment. Management of VA-ECLS is complex and requires constant support of trained personnel. This review describes the indications, daily clinical management and complications of VA-ECLS in patients with cardiogenic shock refractory to conventional strategies. The other selected article is entitled ‘Nationwide claims data validated for quality assessments in acute myocardial infarction in the Netherlands’ [3]. In the Netherlands all reimbursements of the Dutch hospitals are processed by insurance companies and registered by a national diagnosis coding system. The data of patients with ST-elevation myocardial infarction and non-ST-elevation myocardial infarction were retrieved from the national coding system, including the prescription of medication during the first year of follow-up. The data from the national diagnosis coding system was compared with the local databases from four selected hospitals. The data retrieved from the coding systems were compared with the local databases to validate diagnosis and treatment coding, to validate the hospital where follow-up had taken place and to validate the follow-up medical treatment after 365 days. The results of this study show that nationwide routinely collected claims data in patients with acute coronary syndromes are highly accurate. These findings offer the opportunity to use national claims data for quality assessments of cardiac care. The first authors of these articles received an educational grant, provided by the NVVC, at the Annual Spring Meeting of the NVVC held at the Postillion Convention Centre WTC in Rotterdam, the Netherlands, on 11 and 12 April 2019. The NHJ would like to congratulate the authors with these awards and thank them for submitting their excellent work to our journal. The editorial board of the NHJ hopes that the Durrer prizes act as a stimulus for authors to send their best paper to our journal.

          Related collections

          Most cited references2

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Nationwide claims data validated for quality assessments in acute myocardial infarction in the Netherlands

          Introduction Since health insurance is compulsory in the Netherlands, the centrally registered medical claims data might pose a unique opportunity to evaluate quality of (cardiac) care on a national level without additional collection of data. However, validation of these claims data has not yet been assessed. Design Retrospective cohort study. Methods National claims data (‘national registry’) were compared with data collected by patient records reviews in four representative hospitals (‘validation registry’). In both registries, we extracted the national diagnosis codes for ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction of 2012 and 2013. Additionally, data on medication use at one year after acute myocardial infarction (AMI) was extracted from the Dutch pharmacy information systems and also validated by local patient records reviews. The data were compared at three stages: 1) validation of diagnosis and treatment coding; 2) validation of the hospital where follow-up has taken place; 3) validation of follow-up medical treatment after 365 days. Results In total, 3,980 patients (‘national registry’) and 4,014 patients (‘validation registry’) were compared at baseline. After one-year follow-up, 2,776 and 2,701 patients, respectively, were evaluated. Baseline characteristics, diagnosis and individual medication were comparable between the two registries. Of all 52,672 AMI patients in the Netherlands in 2012 and 2013, 81% used aspirin, 76% used P2Y12 inhibitors, 85% used statins, 82% used beta-blockers and 74% angiotensin converting enzyme inhibitors/angiotensin II antagonists. Optimal medical treatment was achieved in 49% of the patients with AMI. Conclusion Nationwide routinely collected claims data in patients with an acute myocardial infarction are highly accurate. This offers an opportunity for use in quality assessments of cardiac care.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Extracorporeal life support in cardiogenic shock: indications and management in current practice

            Veno-arterial extracorporeal life support (VA-ECLS) provides circulatory and respiratory stabilisation in patients with severe refractory cardiogenic shock. Although randomised controlled trials are lacking, the use of VA-ECLS is increasing and observational studies repeatedly have shown treatment benefits in well-selected patients. Current clinical challenges in VA-ECLS relate to optimal management of the individual patient on extracorporeal support given its inherent complexity. In this review article we will discuss indications, daily clinical management and complications of VA-ECLS in cardiogenic shock refractory to conventional treatment strategies.
              Bookmark

              Author and article information

              Contributors
              j.j.piek@amc.uva.nl
              Journal
              Neth Heart J
              Neth Heart J
              Netherlands Heart Journal
              Bohn Stafleu van Loghum (Houten )
              1568-5888
              1876-6250
              10 April 2019
              10 April 2019
              May 2019
              : 27
              : 5
              : 229-230
              Affiliations
              AMC Heart Center, Amsterdam UMC, location AMC , Amsterdam, The Netherlands
              Article
              1278
              10.1007/s12471-019-1278-6
              6470225
              30969395
              16b7a7a7-62bf-4cab-947c-a28ca4224d1b
              © The Author(s) 2019

              Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

              History
              Categories
              Nvvc
              Custom metadata
              © The Author(s) 2019

              Cardiovascular Medicine
              Cardiovascular Medicine

              Comments

              Comment on this article